Peter F. Schmid
AuthID: R-000-QRP
11
TÃTULO: MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer
AUTORES: Peter Schmid; Matthias Zaiss; Catherine Harper Wynne; Marta Ferreira; Sidharth Dubey; Stephen Chan; Andreas Makris; Gia Nemsadze; Adrian M Brunt; Sherko Kuemmel; Isabel Ruiz Cabrero; Antonia Perello; Anne Kendall; Janet Brown; Hartmut Kristeleit; John Conibear; Cristina Saura; Julien Grenier; Karoly Mahr; Michael Schenker; ...Mais
PUBLICAÇÃO: 2018, FONTE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 78, NÚMERO: 4
AUTORES: Peter Schmid; Matthias Zaiss; Catherine Harper Wynne; Marta Ferreira; Sidharth Dubey; Stephen Chan; Andreas Makris; Gia Nemsadze; Adrian M Brunt; Sherko Kuemmel; Isabel Ruiz Cabrero; Antonia Perello; Anne Kendall; Janet Brown; Hartmut Kristeleit; John Conibear; Cristina Saura; Julien Grenier; Karoly Mahr; Michael Schenker; ...Mais
PUBLICAÇÃO: 2018, FONTE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 78, NÚMERO: 4
INDEXADO EM: 
WOS
WOS